Risk of unexpected defects in advanced products
First written in FY2016. 17 of 21 entries say "Restated". Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024MitigatedAnnual report
「In its medium-term management plan, which began in the fiscal year ending June 2024, the Group is strengthening its manufacturing capabilities and enhancing operations in upstream processes, where costs, reliability, and specifications are determined. In addition to incorporating value engineering to improve product maturity and quality improvement mechanisms, such as horizontally deploying information on nonconformities, the Group is implementing and rigorously enforcing measures to prevent recurrence.」
The response to the risk of defects in advanced products specified upstream processes, value engineering, horizontal deployment of information on nonconformities, and measures to prevent recurrence. - FY2023-Q3RestatedAnnual report
「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there had been no material changes regarding the risk of unexpected defects in advanced products. - FY2023-Q2RestatedAnnual report
「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there had been no material changes regarding the risk of unexpected defects in advanced products. - FY2022MitigatedAnnual report
「We are pursuing value engineering to improve product maturity. As part of this effort, we are incorporating quality improvement mechanisms and implementing and rigorously enforcing measures to prevent recurrence.」
In response to quality risks, the disclosure specified value engineering, quality improvement mechanisms, and the implementation and rigorous enforcement of measures to prevent recurrence. - FY2022-Q3RestatedAnnual report
「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. - FY2021-Q3RestatedAnnual report
「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. - FY2021-Q2RestatedAnnual report
「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. - FY2021-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. - FY2020MitigatedAnnual report
「Under the new medium-term management plan beginning with the fiscal year ending June 2021, our group will work to strengthen its manufacturing capabilities. We will improve quality by increasing the completeness of technical drawings and strengthening value engineering at the design stage, while designing production processes that shorten manufacturing lead times and reduce the manufacturing burden. We will also promote specialization and the development of expertise by consolidating production sites for each business.」
Responses to the risk of defects in advanced products were specified as drawing quality, value engineering during the design stage, and consolidation and specialization of production sites. - FY2020-Q2RestatedAnnual report
「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. - FY2020-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. - FY2019RestatedAnnual report
「However, because we consistently provide products that use cutting-edge technologies, they contain substantial development elements, and we anticipate that unexpected defects may occur, resulting in substantial additional costs or lower sales due to a loss of confidence, this could adversely affect our group's operating results and financial position.」
The risk of unexpected defects in cutting-edge products continued, and the specific impacts of additional costs and lower sales due to a loss of confidence were described. - FY2019-Q3RestatedAnnual report
「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. - FY2019-Q2RestatedAnnual report
「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. - FY2019-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. - FY2018RestatedAnnual report
「However, because we consistently provide products that use cutting-edge technologies, they contain substantial development elements, and we anticipate that unexpected defects may occur, requiring us to take corrective action. In such cases, this could adversely affect our group's operating results and financial position.」
The risk of unexpected defects in cutting-edge products continued to be disclosed. - FY2018-Q3RestatedAnnual report
「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. No quantification or occurrence of the risk was indicated. - FY2018-Q2RestatedAnnual report
「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. - FY2018-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
It was stated that there had been no material changes in the risk of unexpected defects in cutting-edge products. - FY2017RestatedAnnual report
「However, because we consistently provide products that use cutting-edge technologies, they contain substantial development elements, and we anticipate that unexpected defects may occur, requiring us to take corrective action.」
The risk of unexpected defects in cutting-edge products continued to be disclosed. - FY2016First statedAnnual report
「However, because we consistently provide products that use cutting-edge technologies, they contain substantial development elements, and we anticipate that unexpected defects may occur, requiring us to take corrective action.」
This was stated together with an explanation that a quality-assurance system, including ISO9001, had been established.